Krystal Biotech KRYS has outperformed the market over the past 5 years by 11.82% on an annualized basis producing an average annual return of 26.13%. Currently, Krystal Biotech has a market capitalization of $5.14 billion.

Buying $1000 In KRYS: If an investor had bought $1000 of KRYS stock 5 years ago, it would be worth $2,869.50 today based on a price of $178.29 for KRYS at the time of writing.

Krystal Biotech's Performance Over Last 5 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.